+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth

  • ID: 5353060
  • Report
  • June 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott Laboratories
  • Biocartis
  • Cleaver Scientific
  • GeneMe
  • Illumina, Inc.
  • Novartis AG
Molecular Diagnostics Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global molecular diagnostics devices and equipment market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the molecular diagnostics devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Lending market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider molecular diagnostics devices and equipment market, and compares it with other markets.

The report covers the following chapters:
  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by product, segmentation by end-user, segmentation by technology and segmentation by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the molecular diagnostics devices and equipment market. This chapter also defines and describes goods and related services covered in the report.
  • Trends and Strategies - This chapter describes the major trends shaping the global molecular diagnostics devices and equipment market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the molecular diagnostics devices and equipment market.
  • Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison - The global molecular diagnostics devices and equipment market comparison with macro-economic factors gives the molecular diagnostics devices and equipment market size, percentage of GDP, and average Molecular Diagnostics Devices and Equipment market expenditure.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global molecular diagnostics devices and equipment market, estimated market shares and company profiles for the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recommendations - This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope

Markets Covered:

1) By Product: Instruments; Reagents and Consumables; Software
2) By End-User: Diagnostic Laboratories; Hospitals; Others
3) By Technology: DNA (Deoxyribonucleic Acid) Sequencing; Polymerase Chain Reaction; Isothermal Nucleic Acid Amplification Technology; Transcription Mediated Amplification (TMA); In Situ Hybridization; Microarrays; Other Technologies
4) By Application: Cancer; Pharmacogenomics; Genetic Testing; Infectious Disease; Prenatal; Other Applications

Companies Mentioned: F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Hologic; Abbott Laboratories; Danaher Corporation

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, molecular diagnostics devices and equipment indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biocartis
  • Cleaver Scientific
  • GeneMe
  • Illumina, Inc.
  • Novartis AG
1. Molecular Diagnostics Devices and Equipment Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Product
6.3. Segmentation By End-User
6.4. Segmentation By Technology
6.5. Segmentation By Application

7. Molecular Diagnostics Devices and Equipment Market Characteristics
7.1. Market Definition
7.2. Segmentation By Product
7.2.1. Instruments
7.2.2. Reagents and Consumables
7.2.3. Software
7.3. Segmentation By End-User
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals
7.3.3. Others
7.4. Segmentation By Technology
7.4.1. DNA (Deoxyribonucleic Acid) Sequencing
7.4.2. Polymerase Chain Reaction
7.4.3. Isothermal Nucleic Acid Amplification Technology
7.4.4. Transcription Mediated Amplification (TMA)
7.4.5. In Situ Hybridization
7.4.6. Microarrays
7.4.7. Other Technologies
7.5. Segmentation By Application
7.5.1. Cancer
7.5.2. Pharmacogenomics
7.5.3. Genetic Testing
7.5.4. Infectious Disease
7.5.5. Prenatal
7.5.6. Other Applications

8. Molecular Diagnostics Devices and Equipment Market Trends and Strategies
8.1. Automation In The Field Of Molecular Diagnostics
8.2. Use Of Artificial Intelligence
8.3. Increased Demand For Molecular Diagnostic Devices In Studying Rare Diseases
8.4. Growing Adoption Of Big Data
8.5. Next Generation Sequencing For Newborn Screening
8.6. Point-Of-Care Molecular Diagnostics (POC MDx)

9. Impact Of COVID-19 On The Molecular Diagnostics Devices and Equipment Market
9.1. Increased Demand For Lab Testing
9.2. Increased Demand For Point-Of-Care Molecular Testing
9.3. Impact On Major Companies

10. Global Molecular Diagnostics Devices and Equipment Market Size and Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025

11. Global Molecular Diagnostics Devices and Equipment Market Segmentation
11.1. Global Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. Reagents and Consumables
11.1.2. Instruments
11.1.3. Software
11.2. Global Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2.1. Diagnostic Laboratories
11.2.2. Hospitals
11.2.3. Others
11.3. Global Molecular Diagnostics Devices and Equipment Market, Segmentation By Technology, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.3.1. DNA (Deoxyribonucleic Acid) Sequencing
11.3.2. Polymerase Chain Reaction
11.3.3. Microarrays
11.3.4. Isothermal Nucleic Acid Amplification Technology
11.3.5. Other Technologies
11.3.6. Transcription Mediated Amplification (TMA)
11.3.7. In Situ Hybridization
11.4. Global Molecular Diagnostics Devices and Equipment Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.4.1. Genetic Testing
11.4.2. Cancer
11.4.3. Prenatal
11.4.4. Infectious Disease
11.4.5. Other Applications
11.4.6. Pharmacogenomics

12. Molecular Diagnostics Devices and Equipment Market, Regional and Country Analysis
12.1. Global Molecular Diagnostics Devices and Equipment Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Molecular Diagnostics Devices and Equipment Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Molecular Diagnostics Devices and Equipment Market
13.1. Asia-Pacific Molecular Diagnostics Devices and Equipment Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID 19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Asia-Pacific Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.4. Asia-Pacific Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Molecular Diagnostics Devices and Equipment Market: Country Analysis
13.7. China Molecular Diagnostics Devices and Equipment Market
13.8. China Molecular Diagnostics Devices and Equipment Market Overview
13.9. China Molecular Diagnostics Devices and Equipment Market Overview
13.9.1. Country Information
13.9.2. Market Information
13.9.3. COVID-19 Impact
13.9.4. Background information
13.9.5. Government Initiatives
13.9.6. Regulations
13.9.7. Regulatory Bodies
13.9.8. Major Associations
13.9.9. Taxes levied
13.9.10. Corporate Tax Structure
13.9.11. Investments
13.9.12. Major Companies
13.10. China Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.11. China Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.12. China Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.13. China Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.14. India Molecular Diagnostics Devices and Equipment Market
13.15. India Molecular Diagnostics Devices and Equipment Market Overview
13.15.1. Country Information
13.15.2. Market Information
13.15.3. COVID 19 Impact
13.15.4. Background information
13.15.5. Government Initiatives
13.15.6. Regulations
13.15.7. Regulatory Bodies
13.15.8. Major Associations
13.15.9. Taxes levied
13.15.10. Corporate Tax Structure
13.15.11. Investments
13.15.12. Major Companies
13.16. India Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.17. India Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.18. India Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.19. India Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.20. Japan Molecular Diagnostics Devices and Equipment Market
13.21. Japan Molecular Diagnostics Devices and Equipment Market Overview
13.21.1. Country Information
13.21.2. Market Information
13.21.3. COVID 19 Impact
13.21.4. Background information
13.21.5. Government Initiatives
13.21.6. Regulations
13.21.7. Regulatory Bodies
13.21.8. Major Associations
13.21.9. Taxes levied
13.21.10. Corporate Tax Structure
13.21.11. Investments
13.21.12. Major Companies
13.22. Japan Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.23. Japan Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.24. Japan Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.25. Japan Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.26. Australia Molecular Diagnostics Devices and Equipment Market
13.27. Australia Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.28. Australia Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.29. Australia Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.30. Australia Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.31. Indonesia Molecular Diagnostics Devices and Equipment Market
13.32. Indonesia Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.33. Indonesia Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.34. Indonesia Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.35. Indonesia Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.36. South Korea Molecular Diagnostics Devices and Equipment Market
13.37. South Korea Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.38. South Korea Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.39. South Korea Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.40. South Korea Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Molecular Diagnostics Devices and Equipment Market
14.1. Western Europe Molecular Diagnostics Devices and Equipment Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. COVID-19 Impact
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Western Europe Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.4. Western Europe Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Molecular Diagnostics Devices and Equipment Market: Country Analysis
14.7. UK Molecular Diagnostics Devices and Equipment Market
14.8. UK Molecular Diagnostics Devices and Equipment Market Overview
14.8.1. Country Information
14.8.2. Market Information
14.8.3. COVID-19 Impact
14.8.4. Background Information
14.8.5. Government Initiatives
14.8.6. Regulations
14.8.7. Regulatory Bodies
14.8.8. Major Associations
14.8.9. Taxes levied
14.8.10. Corporate Tax Structure
14.8.11. Investments
14.8.12. Major Companies
14.9. UK Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.10. UK Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.11. UK Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.12. UK Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.13. Germany Molecular Diagnostics Devices and Equipment Market
14.14. Germany Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.15. Germany Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.16. Germany Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.17. Germany Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.18. France Molecular Diagnostics Devices and Equipment Market
14.19. France Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.20. France Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.21. France Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.22. France Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Molecular Diagnostics Devices and Equipment Market
15.1. Eastern Europe Molecular Diagnostics Devices and Equipment Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.3. Eastern Europe Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.4. Eastern Europe Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Molecular Diagnostics Devices and Equipment Market: Country Analysis
15.7. Russia Molecular Diagnostics Devices and Equipment Market
15.8. Russia Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.9. Russia Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.10. Russia Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Molecular Diagnostics Devices and Equipment Market
16.1. North America Molecular Diagnostics Devices and Equipment Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. North America Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.4. North America Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Molecular Diagnostics Devices and Equipment Market: Country Analysis
16.7. USA Molecular Diagnostics Devices and Equipment Market
16.8. USA Molecular Diagnostics Devices and Equipment Market Overview
16.8.1. Country Information
16.8.2. Market Information
16.8.3. COVID-19 Impact
16.8.4. Background Information
16.8.5. Government Initiatives
16.8.6. Regulations
16.8.7. Regulatory Bodies
16.8.8. Major Associations
16.8.9. Taxes Levied
16.8.10. Corporate Tax Structure
16.8.11. Investments
16.8.12. Major Companies
16.9. USA Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.10. USA Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.11. USA Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Molecular Diagnostics Devices and Equipment Market
17.1. South America Molecular Diagnostics Devices and Equipment Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. COVID-19 Impact
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Major Companies
17.2. South America Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.3. South America Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.4. South America Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Molecular Diagnostics Devices and Equipment Market: Country Analysis
17.7. Brazil Molecular Diagnostics Devices and Equipment Market
17.8. Brazil Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.9. Brazil Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.10. Brazil Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Molecular Diagnostics Devices and Equipment Market
18.1. Middle East Molecular Diagnostics Devices and Equipment Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Middle East Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.4. Middle East Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Molecular Diagnostics Devices and Equipment Market
19.1. Africa Molecular Diagnostics Devices and Equipment Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes levied
19.1.9. Corporate Tax structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Molecular Diagnostics Devices and Equipment Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.3. Africa Molecular Diagnostics Devices and Equipment Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.4. Africa Molecular Diagnostics Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Molecular Diagnostics Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Molecular Diagnostics Devices and Equipment Market Competitive Landscape
20.1. F. Hoffmann-La Roche Ltd
20.1.1. Company Overview
20.1.2. Products and Services
20.1.3. Business Strategy
20.1.4. Financial Overview
20.2. QIAGEN N. V.
20.2.1. Company Overview
20.2.2. Products and Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Hologic
20.3.1. Company Overview
20.3.2. Products and Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Abbott Laboratories
20.4.1. Company Overview
20.4.2. Products and Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Danaher Corporation
20.5.1. Company Overview
20.5.2. Products and Services
20.5.3. Business Strategy
20.5.4. Financial Overview

21. Key Mergers and Acquisitions In The Molecular Diagnostics Devices and Equipment Market
21.1. Veracyte Announced The Acquisition Of Decipher Biosciences
21.2. Hologic Acquired Biotheranostics
21.3. Qiagen Acquired Neumodx Molecular
21.4. Edan Diagnostics Acquired LGC’s ClariLight Molecular Diagnostics Point Of Care (POC) Platform
21.5. Meridian Bioscience Acquired GenePOC Inc.
21.6. Bruker Acquired Majority Interest In Hain Lifescience GmbH
21.7. Myriad Genetics Acquired Counsyl

22. Molecular Diagnostics Devices and Equipment Market Future Outlook and Potential Analysis
22.1. Global Molecular Diagnostics Devices and Equipment Market In 2025 - Countries Offering Most New Opportunities
22.2. Global Molecular Diagnostics Devices and Equipment Market In 2025 - Segments Offering Most New Opportunities
22.3. Global Molecular Diagnostics Devices and Equipment Market In 2025 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher
23.6. Copyright and Disclaime
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biocartis
  • Cleaver Scientific
  • GeneMe
  • Illumina, Inc.
  • Novartis AG
This report describes and explains the global molecular diagnostics devices and equipment market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) at a molecular level. It helps doctors to prescribe more accurate therapeutic interventions in the early stages of a disease. Molecular diagnostics devices and equipment are segmented by product into instruments, reagents, consumables and software. These devices and equipment are used in diagnostic laboratories, hospitals and by other end-users such as nursing homes, blood banks and clinical point of care settings.

The global molecular diagnostics devices and equipment market reached a value of nearly $18,074.7 million in 2020, having increased at a compound annual growth rate (CAGR) of 26.0% since 2015. The market is expected to grow from $18,074.7 million in 2020 to $19,011.3 million in 2025 at a rate of 1.0%. The market is then expected to grow at a CAGR of 6.9% from 2025 and reach $26,508.0 million in 2030.

Growth in the historic period resulted from rise in funding, increase in healthcare expenditure, economic growth in emerging markets, rapid technological advances, emergence of novel pathogenic infestations, and rapid growth in geriatric population. The market was restrained by political uncertainties, regulatory challenges, reduction in free trade, and low healthcare reimbursements.

Going forward rapid rise in various bacterial and viral epidemics, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for molecular diagnostic devices and equipment due to COVID-19 will drive the growth. Factors that could hinder the growth of the molecular diagnostics devices and equipment market in the future include lack of well-defined regulatory framework, ethical concerns related to genomic study, high costs of tests and lack of skilled/trained molecular biologists.

The molecular diagnostics devices and equipment market is segmented by product into instruments, reagents and consumables and software. The reagents and consumables market was the largest segment of the molecular diagnostics devices and equipment market segmented by product, accounting for 60.6% of the total in 2020. Going forward, the software segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by product, at a CAGR of 1.3% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by end-user into diagnostic laboratories, hospitals and others. The diagnostic laboratories market was the largest segment of the molecular diagnostics devices and equipment market segmented by end-user, accounting for 52.5% of the total in 2020. Going forward, the diagnostic laboratories segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by end-user, at a CAGR of 1.1% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by technology into DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, others (southern blotting, northern blotting, electrophoresis). The DNA (deoxyribonucleic acid) sequencing market was the largest segment of the molecular diagnostics devices and equipment market segmented by technology, accounting for 29.0% of the total in 2020. Going forward, the transcription mediated amplification (TMA) segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by technology, at a CAGR of 1.2% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by application into cancer, pharmacogenomics, genetic testing, infectious disease, prenatal, neurological disease, and cardiovascular disease. The genetic testing market was the largest segment of the molecular diagnostics devices and equipment market segmented by application, accounting for 41.8% of the total in 2020. Going forward, the infectious disease segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by application, at a CAGR of 1.3% during 2020-2025.

North America was the largest region in the global molecular diagnostics devices and equipment market, accounting for 34.5% of the total in 2020. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the molecular diagnostics devices and equipment market will be South America and Eastern Europe, where growth will be at CAGRs of 4.1% and 3.8% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 3.7% and 3.1% respectively.

The molecular diagnostics devices and equipment market is highly concentrated, with a small number of large players dominating the market. The key players in the market are focusing on expanding their operational and business presence in the molecular diagnostics market through development of innovative technologies and strategic acquisition of emerging companies in the industry. The top 10 companies in the market occupied 70.30% of market share in the global molecular diagnostics devices and equipment market. Major players in the market include F. Hoffmann-La Roche Ltd, Danaher Corporation, QIAGEN N. V., Hologic, Biomérieux, Siemens Healthineers AG, Becton, Dickinson & Co, Abbott Laboratories, Grifols, S. A., and Sysmex Corporation.

The top opportunities in the molecular diagnostics devices and equipment market segmented by product will arise in the reagents and consumables segment, which will gain $610.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by end-user will arise in the diagnostic laboratories segment, which will gain $530.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by technology will arise in the DNA (deoxyribonucleic acid) sequencing segment, which will gain $304.7 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by application will arise in the genetic testing segment, which will gain $345.8 million of global annual sales by 2025. The molecular diagnostics devices and equipment market size will gain the most in the Japan at $171.3 million.

Market-trend-based strategies for the molecular diagnostics devices and equipment market include automation in the field of molecular diagnostics, use of artificial intelligence, increased demand for molecular diagnostic devices in studying rare diseases, growing adoption of big data, next generation sequencing for newborn screening, and point-of-care molecular diagnostics (POC MDx).

Player-adopted strategies in the molecular diagnostics devices and equipment market include development of advanced and innovative laboratory solutions, acquisition of emerging and established companies in molecular diagnostics, and of innovative technologies.

To take advantage of these opportunities, the publisher recommends the molecular diagnostics devices and equipment manufacturing companies to focus on the use of automation and artificial intelligence (AI) to enhance productivity and consistency of the whole diagnostic process, expanding activities to emerging markets to gain market share, offer competitively priced products to attract the users, use online portals, business websites and listing websites and participate in trade shows and events to reach targeted audience, among other strategies.

Amidst the unprecedented outbreak of corona virus, governments across the world are advising people to stay indoors and practice social distancing, to reduce the spread of the pandemic. Its impact has been seen on the global molecular diagnostics devices and equipment market. The pandemic has accelerated the adoption of molecular diagnostics devices and equipment in the healthcare industry, highlighting the power of sequencing-based diagnostic testing in global efforts to combat the spread of the infectious diseases, and its importance in supporting recovery efforts.
Note: Product cover images may vary from those shown
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Hologic
  • Abbott Laboratories
  • Danaher Corporation
  • Biomérieux
  • Becton, Dickinson & Co
  • Siemens Healthineers AG
  • Grifols, S.A.
  • Sysmex Corporation
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad laboratories India Pvt.Ltd
  • Cleaver Scientific
  • QuantuMDx
  • Interlabservis
  • GeneMe
  • TestLine Clinical Diagnostics s.r.o.
  • Johnson & Johnson
  • Illumina, Inc.
  • Novartis AG
  • Cepheid, Inc.
  • Ortho Clinical Diagnostics, Inc
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific
  • Grifols International S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll